Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Omicron Variant of COVID-19”

Showing 18 of 0 results

Large-scale testing (Phase 3)UnknownNCT05308576
What this trial is testing

Evaluate the Efficacy and Safety of SCTV01E (a COVID-19 Vaccine) in Population Aged ≥18 Years

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 10,000
Not applicableStudy completedNCT05951920
What this trial is testing

Lymph Node Aspiration to Decipher the Immune Response of Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated With at Least 3 Doses of COVID-19 mRNA Vaccine.

Who this might be right for
COVID-19
Assistance Publique - Hôpitaux de Paris 12
Not applicableStudy completedNCT05240183
What this trial is testing

Viral Dynamics of Omicron in Children

Who this might be right for
SARS-CoV2 Infection, COVID-19
The Hospital for Sick Children 107
Not applicableStudy completedNCT05813600
What this trial is testing

Efficacy and Safety of Nirmatrelvir/Ritonavir for Treating Omicron Variant of COVID-19

Who this might be right for
Omicron Variant of COVID-19
Xiangao Jiang 58
Testing effectiveness (Phase 2)UnknownNCT05238441
What this trial is testing

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01E in Population Aged ≥18 Years Previously Fully Vaccinated With mRNA COVID-19 Vaccine

Who this might be right for
COVID-19Sars-CoV-2 Infection
Sinocelltech Ltd. 360
Testing effectiveness (Phase 2)UnknownNCT05239806
What this trial is testing

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E in Population Aged ≥12 Years Previously Fully Vaccinated With Inactivated COVID-19 Vaccine

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 400
Large-scale testing (Phase 3)UnknownNCT05323461
What this trial is testing

Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 1,800
Large-scale testing (Phase 3)Study completedNCT05249829
What this trial is testing

Evaluate the Immunogenicity and Safety of Omicron Variant Vaccines in Comparison With mRNA-1273 Booster Vaccine for COVID-19

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 3,548
Not applicableUnknownNCT05745545
What this trial is testing

Clinical Trial of COVID-19 Vaccine（SARS-CoV-2 Variant(Omicron BA.5) mRNA Vaccine） in Participants Aged 18 Years and Over

Who this might be right for
SARS-CoV-2
AIM Vaccine Co., Ltd. 3,200
Large-scale testing (Phase 3)Study completedNCT04649151
What this trial is testing

Evaluate the Safety, Reactogenicity, and Effectiveness of mRNA-1273 Vaccine in Adolescents 12 to <18 Years Old to Prevent COVID-19

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 4,328
Large-scale testing (Phase 3)Study completedNCT05973006
What this trial is testing

Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines

Who this might be right for
COVID-19
Novavax 400
Testing effectiveness (Phase 2)Study completedNCT05593042
What this trial is testing

Immunogenicity Evaluation of Omicron Variant-based Vaccine and a Trivalent Vaccine in Adults Against COVID-19 in Chile

Who this might be right for
COVID-19Vaccines
Pontificia Universidad Catolica de Chile 551
Testing effectiveness (Phase 2)Study completedNCT05289037
What this trial is testing

COVID-19 Variant Immunologic Landscape Trial (COVAIL Trial)

Who this might be right for
COVID-19
National Institute of Allergy and Infectious Diseases (NIAID) 1,270
Large-scale testing (Phase 3)UnknownNCT05616754
What this trial is testing

A Trial Evaluate the Immunogenicity and Safety of Recombinant COVID-19 Omicron-Delta Variant Vaccine (CHO Cell)

Who this might be right for
COVID-19
Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. 400
Large-scale testing (Phase 3)Study completedNCT05381350
What this trial is testing

Immunogenicity and Safety of Booster Immunization of COVID-19 Vaccine (Vero Cell), Inactivated (Omicron Variant) in Healthy People Aged 18 Years and Above

Who this might be right for
COVID-19
Sinovac Research and Development Co., Ltd. 1,750
Large-scale testing (Phase 3)UnknownNCT05749926
What this trial is testing

Immunogenicity and Reactogenicity of the Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated With at Least 3 Doses of COVID-19 mRNA Vaccine

Who this might be right for
Vaccine ReactionCOVID-19
Assistance Publique - Hôpitaux de Paris 248
Post-approval studies (Phase 4)Study completedNCT07834073
What this trial is testing

Immunogenicity and Safety of a Single Dose of mRNA SARS-CoV-2 Vaccine in Chinese Adults With Hybrid Immunity

Who this might be right for
COVID-19SARS-CoV-2 Infection
Jiangsu Province Centers for Disease Control and Prevention 2,052
Very early researchUnknownNCT05585567
What this trial is testing

A Preliminary Exploratory Study to Evaluate the Safety and Immunogenicity of Omicron Variant Bivalent Vaccine V-01-B5

Who this might be right for
COVID-19 Pandemic
Livzon Pharmaceutical Group Inc. 48

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation